AstraZeneca is the latest major drugmaker to strike a deal with the Trump administration on lowering U.S. drug prices,
PositiveHealth

AstraZeneca has joined the ranks of major drugmakers making strides to lower U.S. drug prices by striking a deal with the Trump administration. This agreement introduces 'most-favored nation' pricing, which aims to ensure that Americans pay no more than the lowest price available for medications. This move follows Pfizer's recent commitment to reduce prices for its drugs sold through Medicaid and the upcoming TrumpRx direct-purchasing service. Such initiatives are crucial as they could significantly alleviate the financial burden on patients and reshape the pharmaceutical landscape.
— Curated by the World Pulse Now AI Editorial System